BRYCE NORMAN: Open Payments
NPI 1669082541 · WATSONTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,727 in 148 payments from 19 companies in 2025. Trend: 2023 $2,305 · 2024 $2,723 · 2025 $2,727
Food & beverage: $2,727
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 30 | $529 |
| ABBVIE INC. | 31 | $515 |
| Lilly USA, LLC | 12 | $223 |
| AstraZeneca Pharmaceuticals LP | 8 | $202 |
| PFIZER INC. | 13 | $189 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $180 |
| Exact Sciences Corporation | 8 | $178 |
| Amgen Inc. | 10 | $154 |
| Phathom Pharmaceuticals, Inc. | 5 | $149 |
| GlaxoSmithKline, LLC. | 6 | $102 |
Products named: Ozempic, VRAYLAR, CAPLYTA, QULIPTA, VOQUEZNA, FARXIGA, UBRELVY, JARDIANCE.
Industry payments across PA — which companies pay providers there.
